Cryosleep technology has its roots in experiments dating back to the 1960s. Some of the earliest attempts to induce a state of suspended animation through cryogenic freezing involved scientists like Dr. James Bedford. In 1967, Bedford successfully froze and revived a dog using a circulating liquid with antifreeze properties. However, the animal experienced brain damage and other complications. Throughout the late 1960s and 1970s, various teams experimented with freezing small animals with limited success. While some survived the freezing and thawing process intact, many suffered neurological or cellular damage that proved fatal.
It was not until the 1980s that scientists began achieving more promising results with larger animals. A team at the University of Pittsburgh led by Dr. Samuel Tarelnick used a technique known as vitrification to freeze dogs without forming ice crystals. Vitrification circumvents the dangers of ice crystallization at the cellular level by turning tissues directly into a glass-like state through ultra-rapid freezing. The dogs survived without apparent harm. Testing continued through the 1990s involving pigs, monkeys, and other larger test subjects with vitrification techniques. By the 2000s, scientists could reliably freeze and revive larger mammals intact and healthy.
Developing Vitrification Technologies for Human Cryosleep
While remarkable progress has been made freezing and reviving larger animals, major challenges remain to applying Cryosleep technology safely to humans. A key focus of ongoing research involves further developing vitrification agents and protocols that can safely bring the entire human body, including the brain, down to cryogenic temperatures without damage. Several compounds show promise as blood substitutes and cryoprotectants, including various sugars and polymers, but require more testing. Technical challenges also exist in developing systems capable of achieving the necessary ultra-fast cooling and rewarming rates across the entire human body uniformly and without freezing of tissues.
Beyond technical challenges, gaining approval for human testing also poses regulatory difficulties. No regulatory body has approved trials involving human cryopreservation for reasons of safety and medical ethics. Researchers must demonstrate techniques can reliably resuscitate humans without harm before regulators will approve its testing on terminally ill patients. Continuous life support also poses issues during long-term, underground storage that would be needed to preserve patients until future medical advances could potentially revive them.
Applications of Technology
If scientists can overcome the remaining hurdles, human technology could have numerous applications. Perhaps the most discussed application involves its potential use for treating currently incurable medical conditions. Cryopreservation may allow storing patients with terminal cancers, genetic disorders, or other diseases until advances provide a cure. It could also enable emergency medicine applications like preserving severely injured trauma victims in a suspended state until definitive care is available.
Beyond medical uses, cryosleep raises the possibility of extended human lifespans through techniques like embryonic or neo-natal preservation. This could enable "re-aging" individuals to healthier younger clone bodies in the future. More speculatively, cryopreservation may even facilitate speculated future technologies like mind uploading by preserving the brain and consciousness intact. Perhaps the highest profile application involves potential uses of cryosleep for deep space exploration. Long-duration interstellar missions could utilize suspended animation to allow smaller crews and life support requirements for multi-generational journeys. Passengers would be safely frozen and stored in an inactive state until reaching their destination decades or centuries later.
Regulatory and Ethical Considerations
Of course, human cryopreservation also presents numerous ethical issues that must be addressed as the technology advances. Chief among concerns are questions around obtaining proper informed consent from terminally ill patients volunteering for experimental freezing. It is unclear patients fully understand risks like the possibility of revival failure or revived in an altered personal identity. Regulators will need procedures to verify consent without coercion from family or financially interested parties. Larger issues also arise around the ownership and storage of preserved humans, how to ensure their legal and ethical "waking", as well as respecting personal preferences regarding revival in some future society potentially very different than today's. Overall, human cryosleep technologies require balancing promise with ethics as researchers work to overcome technical barriers and gain regulatory approval for initial safety testing. Doing so responsibly could usher revolutionary benefits, but improperly may risk human dignity and rights. Continued open discussion will likely be needed.
Cryosleep technology, current technical challenges regarding human applications, potential future uses if successful, and some important regulatory and ethical considerations that must be addressed going forward. While human cryopreservation remains experimental, continued research progress in vital technologies like vitrification offer hope that suspended animation may one day become a medical or lengthened lifespan reality. However, safety and ethical issues will need resolving before regulators sanction initial testing on terminally ill volunteers. Overall, it holds both tremendous potential and responsibility to be developed and applied carefully and conscientiously.
Get more insights on Cryosleep
Comments
0 comment